News
The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion
Nihar Desai, MD, MPH, Jaime Murillo, MD, and Steven Nissen, MD, discuss how cardiovascular outcome trial results are impacting the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with heart failure and how these drugs are shaping heart failure outcomes for patients.
Source: AJMC